Nonalcoholic steatohepatitis (NASH) is a serious and rapidly growing problem affecting a population that was not previously recognized as high risk. Although treatments are limited, shedding light on those with a predisposition may allow for primary prevention, as there is presently no cure other than liver transplant. This study examines the risk factors, genetic predisposition, pathophysiology, and treatment options.
View Article and Find Full Text PDF